Rachel Thompson

Developing the WCRF International/University of Bristol Methodology for Identifying and Carrying Out Systematic Reviews of Mechanisms of Exposure–Cancer Associations

Tom R. Gaunt, Sarah J Lewis, Mike Gardner, 2017, Cancer Epidemiology, Biomarkers & Prevention.

Information Sharing Management (ISM) Team - Training Documents

Rachel Thompson, 2011 .

A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic era

Rachel Thompson, Hanns Lochmüller, Bruno Eymard, 2018, Orphanet Journal of Rare Diseases.

Tumor-targeted RNA-interference: functional non-viral nanovectors.

Rachel Thompson, Daocheng Wu, Liang Xu, 2011, American journal of cancer research.

Linked Registries: Connecting Rare Diseases Patient Registries through a Semantic Web Layer

Núria Queralt-Rosinach, José Luís Oliveira, Rajaram Kaliyaperumal, 2017, BioMed research international.

An ontological foundation for ocular phenotypes and rare eye diseases

Rachel Thompson, Peter N Robinson, Annie Olry, 2019, Orphanet Journal of Rare Diseases.

Mapping the differences in care for 5,000 Spinal Muscular Atrophy patients, a survey of 24 national registries in North America, Australasia and Europe

Thomas Sejersen, Rachel Thompson, Clemens Bloetzer, 2013, Journal of Neurology.

Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome

Paolo Missier, Rachel Thompson, Hanns Lochmüller, 2019, Emerging topics in life sciences.

RD-Connect, NeurOmics and EURenOmics: collaborative European initiative for rare diseases

Rachel Thompson, Hanns Lochmüller, Holm Graessner, 2018, European Journal of Human Genetics.